Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Sep;62(3):337–340. doi: 10.1038/bjc.1990.293

Chemotherapy for advanced bladder cancer: 'Midsummer Night's Dream' or 'Much Ado About Nothing'?

D Raghavan 1
PMCID: PMC1971441  PMID: 2206939

Full text

PDF
339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown J. L., Russell P. J., Philips J., Wotherspoon J., Raghavan D. Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity. Br J Cancer. 1990 Mar;61(3):369–376. doi: 10.1038/bjc.1990.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carter S. K., Wasserman T. H. The chemotherapy of urologic cancer. Cancer. 1975 Aug;36(2):729–747. doi: 10.1002/1097-0142(197508)36:2+<729::aid-cncr2820360818>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  3. Connor J. P., Olsson C. A., Benson M. C., Rapoport F., Sawczuk I. S. Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: cause for concern. Urology. 1989 Dec;34(6):353–356. doi: 10.1016/0090-4295(89)90440-8. [DOI] [PubMed] [Google Scholar]
  4. Eapen L., Stewart D., Danjoux C., Genest P., Futter N., Moors D., Irvine A., Crook J., Aitken S., Gerig L. Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer. J Clin Oncol. 1989 Feb;7(2):230–235. doi: 10.1200/JCO.1989.7.2.230. [DOI] [PubMed] [Google Scholar]
  5. Fagg S. L., Dawson-Edwards P., Hughes M. A., Latief T. N., Rolfe E. B., Fielding J. W. Cis-diamminedichloroplatinum (DDP) as initial treatment of invasive bladder cancer. Br J Urol. 1984 Jun;56(3):296–300. doi: 10.1111/j.1464-410x.1984.tb05390.x. [DOI] [PubMed] [Google Scholar]
  6. Gabrilove J. L., Jakubowski A., Scher H., Sternberg C., Wong G., Grous J., Yagoda A., Fain K., Moore M. A., Clarkson B. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med. 1988 Jun 2;318(22):1414–1422. doi: 10.1056/NEJM198806023182202. [DOI] [PubMed] [Google Scholar]
  7. Gospodarowicz M. K., Hawkins N. V., Rawlings G. A., Connolly J. G., Jewett M. A., Thomas G. M., Herman J. G., Garrett P. G., Chua T., Duncan W. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J Urol. 1989 Dec;142(6):1448–1454. doi: 10.1016/s0022-5347(17)39122-x. [DOI] [PubMed] [Google Scholar]
  8. Hillcoat B. L., Raghavan D., Matthews J., Kefford R., Yuen K., Woods R., Olver I., Bishop J., Pearson B., Coorey G. A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract. J Clin Oncol. 1989 Jun;7(6):706–709. doi: 10.1200/JCO.1989.7.6.706. [DOI] [PubMed] [Google Scholar]
  9. Kaye S. B., MacFarlane J. R., McHattie I., Hart A. J. Chemotherapy before radiotherapy for T3 bladder cancer. A pilot study. Br J Urol. 1985 Aug;57(4):434–437. doi: 10.1111/j.1464-410x.1985.tb06304.x. [DOI] [PubMed] [Google Scholar]
  10. Khandekar J. D., Elson P. J., DeWys W. D., Slayton R. E., Harris D. T. Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinomas of the urinary tract. J Clin Oncol. 1985 Apr;3(4):539–545. doi: 10.1200/JCO.1985.3.4.539. [DOI] [PubMed] [Google Scholar]
  11. Meyers F. J., Palmer J. M., Freiha F. S., Harker E. G., Shortliffe L. D., Hannigan J., McWhirter K., Torti F. M. The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study. J Urol. 1985 Dec;134(6):1118–1121. doi: 10.1016/s0022-5347(17)47651-8. [DOI] [PubMed] [Google Scholar]
  12. Raghavan D., Grundy R., Greenaway T. M., Pearson B. S., Rogers J., Duval P., Meagher M., Mameghan H. Pre-emptive (neo-adjuvant) chemotherapy prior to radical radiotherapy for fit septuagenarians with bladder cancer: age itself is not a contra-indication. Br J Urol. 1988 Aug;62(2):154–159. doi: 10.1111/j.1464-410x.1988.tb04297.x. [DOI] [PubMed] [Google Scholar]
  13. Raghavan D., Pearson B., Duval P., Rogers J., Meagher M., Wines R., Mameghan H., Boulas J., Green D. Initial intravenous cis-platinum therapy: improved management for invasive high risk bladder cancer? J Urol. 1985 Mar;133(3):399–402. doi: 10.1016/s0022-5347(17)48995-6. [DOI] [PubMed] [Google Scholar]
  14. Raghavan D. Pre-emptive (neo-adjuvant) intravenous chemotherapy for invasive bladder cancer. Br J Urol. 1988 Jan;61(1):1–8. doi: 10.1111/j.1464-410x.1988.tb09152.x. [DOI] [PubMed] [Google Scholar]
  15. Raghavan D., Shipley W. U., Garnick M. B., Russell P. J., Richie J. P. Biology and management of bladder cancer. N Engl J Med. 1990 Apr 19;322(16):1129–1138. doi: 10.1056/NEJM199004193221607. [DOI] [PubMed] [Google Scholar]
  16. Rotman M., Macchia R., Silverstein M., Aziz H., Choi K., Rosenthal J., Braverman A., Laungani G. B. Treatment of advanced bladder carcinoma with irradiation and concomitant 5-fluorouracil infusion. Cancer. 1987 Feb 15;59(4):710–714. doi: 10.1002/1097-0142(19870215)59:4<710::aid-cncr2820590408>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  17. Sacks H. S., Berrier J., Reitman D., Ancona-Berk V. A., Chalmers T. C. Meta-analyses of randomized controlled trials. N Engl J Med. 1987 Feb 19;316(8):450–455. doi: 10.1056/NEJM198702193160806. [DOI] [PubMed] [Google Scholar]
  18. Scher H., Herr H., Sternberg C., Fair W., Bosl G., Morse M., Sogani P., Watson R., Dershaw D., Reuter V. Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen. Br J Urol. 1989 Sep;64(3):250–256. doi: 10.1111/j.1464-410x.1989.tb06008.x. [DOI] [PubMed] [Google Scholar]
  19. Schulman C. C., Wespes E., Delcour C., Struyven J. Intra-arterial chemotherapy of infiltrative bladder carcinoma. Eur Urol. 1985;11(4):220–223. doi: 10.1159/000472502. [DOI] [PubMed] [Google Scholar]
  20. Shearer R. J., Chilvers C. F., Bloom H. J., Bliss J. M., Horwich A., Babiker A. Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report. Br J Urol. 1988 Dec;62(6):558–564. doi: 10.1111/j.1464-410x.1988.tb04426.x. [DOI] [PubMed] [Google Scholar]
  21. Shipley W. U., Coombs L. J., Einstein A. B., Jr, Soloway M. S., Wajsman Z., Prout G. R., Jr Cisplatin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response. J Urol. 1984 Nov;132(5):899–903. doi: 10.1016/s0022-5347(17)49938-1. [DOI] [PubMed] [Google Scholar]
  22. Shipley W. U., Kaufman S. D., Prout G. R., Jr The role of radiation therapy and chemotherapy in the treatment of invasive carcinoma of the urinary bladder. Semin Oncol. 1988 Aug;15(4):390–395. [PubMed] [Google Scholar]
  23. Simes R. J. Publication bias: the case for an international registry of clinical trials. J Clin Oncol. 1986 Oct;4(10):1529–1541. doi: 10.1200/JCO.1986.4.10.1529. [DOI] [PubMed] [Google Scholar]
  24. Skinner D. G., Lieskovsky G. Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol. 1984 Jun;131(6):1069–1072. doi: 10.1016/s0022-5347(17)50809-5. [DOI] [PubMed] [Google Scholar]
  25. Soloway M. S., Einstein A., Corder M. P., Bonney W., Prout G. R., Jr, Coombs J. A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study. Cancer. 1983 Sep 1;52(5):767–772. doi: 10.1002/1097-0142(19830901)52:5<767::aid-cncr2820520502>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  26. Sternberg C. N., Yagoda A., Scher H. I., Watson R. C., Ahmed T., Weiselberg L. R., Geller N., Hollander P. S., Herr H. W., Sogani P. C. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol. 1985 Mar;133(3):403–407. doi: 10.1016/s0022-5347(17)48996-8. [DOI] [PubMed] [Google Scholar]
  27. Sternberg C. N., Yagoda A., Scher H. I., Watson R. C., Geller N., Herr H. W., Morse M. J., Sogani P. C., Vaughan E. D., Bander N. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer. 1989 Dec 15;64(12):2448–2458. doi: 10.1002/1097-0142(19891215)64:12<2448::aid-cncr2820641209>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  28. Sternberg C. N., Yagoda A., Scher H. I., Watson R. C., Herr H. W., Morse M. J., Sogani P. C., Vaughan E. D., Jr, Bander N., Weiselberg L. R. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol. 1988 Mar;139(3):461–469. doi: 10.1016/s0022-5347(17)42494-3. [DOI] [PubMed] [Google Scholar]
  29. Troner M., Birch R., Omura G. A., Williams S. Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial. J Urol. 1987 Apr;137(4):660–662. doi: 10.1016/s0022-5347(17)44167-x. [DOI] [PubMed] [Google Scholar]
  30. Van Oosterom A. T., Akaza H., Hall R., Hirao Y., Jones W. G., Matsumura Y., Raghavan D., Tannock I. F., Yagoda A. Response criteria phase II/phase III invasive bladder cancer. Prog Clin Biol Res. 1986;221:301–310. [PubMed] [Google Scholar]
  31. WILSON W. L. Chemotherapy of human solid tumors with 5-fluorouracil. Cancer. 1960 Nov-Dec;13:1230–1239. doi: 10.1002/1097-0142(196011/12)13:6<1230::aid-cncr2820130612>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  32. Zincke H., Sen S. E., Hahn R. G., Keating J. P. Neoadjuvant chemotherapy for locally advanced transitional cell carcinoma of the bladder: do local findings suggest a potential for salvage of the bladder? Mayo Clin Proc. 1988 Jan;63(1):16–22. doi: 10.1016/s0025-6196(12)62659-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES